Systematic Review and Meta-analysis of Prophylactic Mesh During Primary Stoma Formation to Prevent Parastomal Hernia

Stephen J Chapman1, Benjamin Wood, Thomas M Drake

  • 11 Section of Translational Anaesthesia and Surgery, Leeds Institute of Biological and Clinical Sciences, University of Leeds, Leeds, United Kingdom 2 Academic Unit of Surgical Oncology, Department of Oncology and Human Metabolism, University of Sheffield, Sheffield, United Kingdom.

Abstract

Insights

Mesh prophylaxis significantly reduces parastomal hernia rates after stoma formation. This meta-analysis indicates mesh is safe and effective, though larger trials are needed due to study limitations.

Area of Science:

  • Surgical Oncology
  • Gastroenterology
  • Clinical Trials

Background:

  • Parastomal hernias are a common complication following stoma formation.
  • Mesh implantation during stoma creation is a potential preventative strategy.
  • Previous evidence was limited to small, randomized controlled trials.

Purpose of the Study:

  • To conduct an updated systematic review and meta-analysis on mesh prophylaxis for parastomal hernia prevention.
  • To assess the safety and efficacy of mesh in reducing parastomal hernia incidence.
  • To identify ongoing trials and propose future research directions.

Main Methods:

  • Systematic search of MEDLINE, EMBASE, and Cochrane Library up to March 2016.
  • Inclusion of randomized controlled trials comparing mesh versus no mesh.
  • Primary outcome: parastomal hernia rate at 12 months post-stoma formation.

Main Results:

  • Seven randomized controlled trials (432 patients) were included, all with high risk of bias.
  • Mesh significantly reduced clinically detected parastomal hernia (10.8% vs 32.4%).
  • Mesh also reduced radiologically detected parastomal hernia (34.6% vs 55.3%) without increasing complications.

Conclusions:

  • Mesh prophylaxis appears safe and effective in preventing parastomal hernias.
  • Heterogeneity, small sample sizes, and bias necessitate cautious interpretation.
  • Larger, more rigorous randomized controlled trials are justified to confirm findings.